Bellevue Group AG

Q2 2022 13F-HR Detailed Holdings

Location
Kuesnacht, V8
Holdings as of
6/30/2022
Date filed
8/11/2022
Form type
13F-HR
Num holdings
214
Total value ($000)
$7,074,165
Net value change ($000)
-1,537,796 (-17.9%)
New positions
10
Sold out positions
15
Turnover %
0.7%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 5/13/2022 Next filing: 11/14/2022 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ARGX 49,075 16.3%
PFE 41,408 1720.3%
HRMY 28,161 463.3%
JAZZ 25,675 21.8%
CLDX 24,938 NEW
Radius Health, Inc. 17,766 24.2%
CRL 13,546 37.7%
LEGN 10,687 44.6%
PRCT 9,453 94.4%
ESPR 6,988 35.0%
Top Reduces (Value $000, Stocks/ETFs)
ELV -101,587 -50.2%
ARVN -57,253 -39.0%
MRNA -57,071 -20.2%
OM -57,004 -62.2%
VRTX -54,879 -14.2%
REGN -52,574 -83.4%
KZR -52,486 -67.6%
TNDM -51,952 -40.0%
DXCM -50,973 -42.4%
FATE -50,688 -36.6%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892
3 Bellevue Asset Management (UK) Ltd. 28-20408